Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for VERFAHREN ZUR BEHANDLUNG VON KAPOSI-SARKOM ODER KSVH-INDUZIERTEM LYMPHOM UNTER VERWENDUNG IMMUNMODULATORISCHER VERBINDUNGEN UND VERWENDUNGEN VON BIOMARKERN
Details for 2016815375
Up to date per 15.06.2026
Actions
Details for 2016815375
Title / Product Name
VERFAHREN ZUR BEHANDLUNG VON KAPOSI-SARKOM ODER KSVH-INDUZIERTEM LYMPHOM UNTER VERWENDUNG IMMUNMODULATORISCHER VERBINDUNGEN UND VERWENDUNGEN VON BIOMARKERN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2016815375
EP Publication Number
3313818
E-Number
1629522
Language
EN
PCT Number
US16039245
Publication Date
02.05.2018 A
08.11.2023 B1
Registration Date
08.11.2023
AT Publication Date
15.11.2023
Application Date
24.06.2016
Registration Number
-
Priorities
26.06.2015
US
201562185265 P
IPC
C07D 209/48 20060101AFI20181217BHEP
Maximum Duration of Protection
24.06.2036
Owner
Celgene CorporationRoute 206 & Province Line Road Princeton, NJ 08543US
The U.S.A. as represented by the Secretary, Department of Health and Human Services Office of Technology Transfer National Institutes of Health6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, MD 20892-7660 US